Picture: 123RF/LEIGH ANNEF
Picture: 123RF/LEIGH ANNEF

Aspen was recently thrust into the spotlight after research showed that one of the drugs it supplies has reduced deaths in critically ill Covid-19 patients.

Business Day TV spoke to Aspen CEO Stephen Saad about whether the company has the capacity to meet the growing demand for the drug.

Or listen to the full audio: